New paradigms in the prevention of ASCVD: The role of EPA and triglycerides

Episodes 1-4 of 4

• 

  MinuteCE®

  New paradigms in the prevention of ASCVD: The role of EPA and triglycerides

  1.00 credit 3 episodes

  • 

    

    Richard Hobbs, MD

  • 

    

    Lale Tokgözoğlu, MD

  • 

    

    Victor Aboyans, MD, PhD

  1.00 credit 3 episodes

• 

  RestartResume

  The benefits of icosapent ethyl in addressing residual risk: What is the evidence?

  RestartResume

  The benefits of icosapent ethyl in addressing residual risk: What is the evidence?

  MinuteCE®

  The benefits of icosapent ethyl in addressing residual risk: What is the evidence?

  1.00 program credit

  • 

    

    Lale Tokgözoğlu, MD

  1.00 program credit

• 

  RestartResume

  Integrating icosapent ethyl in preventive strategies: Practical guidance

  RestartResume

  Integrating icosapent ethyl in preventive strategies: Practical guidance

  MinuteCE®

  Integrating icosapent ethyl in preventive strategies: Practical guidance

  1.00 program credit

  • 

    

    Victor Aboyans, MD, PhD

  1.00 program credit

• 

  RestartResume

  Reassessing the role of triglycerides in residual cardiovascular risk

  RestartResume

  Reassessing the role of triglycerides in residual cardiovascular risk

  MinuteCE®

  Reassessing the role of triglycerides in residual cardiovascular risk

  1.00 program credit

  • 

    

    Richard Hobbs, MD

  1.00 program credit